BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 24507546)

  • 1. Therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review.
    Bright RJ; Wilkinson J; Coventry BJ
    BMC Neurol; 2014 Feb; 14():26. PubMed ID: 24507546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
    Oaklander AL; Lunn MP; Hughes RA; van Schaik IN; Frost C; Chalk CH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010369. PubMed ID: 28084646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; Brassington R; Gunn AA; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2017 May; 5(5):CD003280. PubMed ID: 28481421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies.
    Tracy JA; Dyck PJ
    Curr Opin Neurol; 2010 Jun; 23(3):242-8. PubMed ID: 20389243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Shije J; Brannagan TH
    Semin Neurol; 2019 Oct; 39(5):596-607. PubMed ID: 31639843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC).
    Bus SRM; Zambreanu L; Abbas A; Rajabally YA; Hadden RDM; de Haan RJ; de Borgie CAJM; Lunn MP; van Schaik IN; Eftimov F;
    Trials; 2021 Feb; 22(1):155. PubMed ID: 33608058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
    Eftimov F; Winer JB; Vermeulen M; de Haan R; van Schaik IN
    Cochrane Database Syst Rev; 2009 Jan; (1):CD001797. PubMed ID: 19160200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy of chronic inflammatory demyelinating polyradiculoneuropathy.
    Eftimov F; van Schaik IN
    Expert Opin Biol Ther; 2008 May; 8(5):643-55. PubMed ID: 18407767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; Swan AV; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2010 Nov; (11):CD003280. PubMed ID: 21069674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2013 Jun; (6):CD003280. PubMed ID: 23771584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
    Van Schaik IN; Winer JB; De Haan R; Vermeulen M
    Cochrane Database Syst Rev; 2002; (2):CD001797. PubMed ID: 12076423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2003; (1):CD003280. PubMed ID: 12535467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment options for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)].
    Kuntzer T
    Rev Neurol (Paris); 2006 Apr; 162(4):539-43. PubMed ID: 16585918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003280. PubMed ID: 15495046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial.
    Hughes R; Dalakas MC; Merkies I; Latov N; Léger JM; Nobile-Orazio E; Sobue G; Genge A; Cornblath D; Merschhemke M; Ervin CM; Agoropoulou C; Hartung HP;
    Lancet Neurol; 2018 Aug; 17(8):689-698. PubMed ID: 30001923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review.
    van Schaik IN; Winer JB; de Haan R; Vermeulen M
    Lancet Neurol; 2002 Dec; 1(8):491-8. PubMed ID: 12849334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA; Mehndiratta MM; Rajabally YA
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD002062. PubMed ID: 29185258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Current Therapies and Future Approaches.
    Svačina MKR; Lehmann HC
    Curr Pharm Des; 2022; 28(11):854-862. PubMed ID: 35339172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic strategy for CIDP (chronic inflammatory demyelinating polyneuropathy)].
    Iijima M; Koike H; Sobue G
    Nihon Rinsho; 2013 May; 71(5):855-60. PubMed ID: 23777094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial.
    Hughes RA
    Expert Rev Neurother; 2009 Jun; 9(6):789-95. PubMed ID: 19496683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.